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 Summary
 Background: Sarcoidosis is a multisystemic inflammatory disease of unknown origin. The lymphoid system and 
the lungs are the most commonly involved organs. The frequency of signs or symptoms of hepatic 
involvement is very low.
 Case Report: We present a case of symptomatic granulomatous liver disease secondary to sarcoidosis, mimicking 
a metastatic disease on ultrasonography and CT.
 Conclusions: Hepatic involvement in sarcoidosis might be a perplexing diagnostic problem. The decisive CT 
finding with respect to the differential diagnosis was the absence of a mass effect and intact 
vascular architecture around the lesions.
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Sarcoidosis is a multisystemic non-caseous granulomatous 
disease of unknown origin. It emerges as hilar adenopathy 
and interstitial lung disease in most of the cases. The cen-
tral nervous system, bones, skin, eyes, liver and spleen can 
also be involved [1]. Fifty to 65% of patients with sarcoido-
sis have histologically proven liver involvement. Therefore, 
patients are usually asymptomatic for hepatic involvement 
[2]. Sarcoidosis presents as focal nodular, hypodense lesions 
in the liver and spleen that can be seen on computed 
tomography (CT) [3].
Case Report
A 67-year-old female with elevated liver function tests and 
increased serum tumor markers (CA 125, CA 19-9 and CA 
15-3) was referred from the hepatology department for a 
CT scan of the chest and abdomen to assess the charac-
teristics of nodular liver lesions that had recently been 
identified on ultrasonography. According to the patient’s 
history, she had been complaining for approximately 2 
months of generalized weakness, fever and mild scle-
ral jaundice. Her past medical history was unremark-
able. Family history was not significant for the presence 
of any malignancy or gastrointestinal disorder. Laboratory 
investigations revealed elevated liver enzyme levels such 
as; g-glutamyl transpeptidase (1668 U/L, reference value 
6–42 U/L), alanine transaminase (201 IU/L, reference value 
4–33 IU/L), aspartate transaminase (163 IU/L, reference 
value 4–32 IU/L), alkaline phosphatase (2098 IU/L, refer-
ence value 35–105 IU/L), total bilirubin (1.83 mg/dL, refer-
ence value <1.2 mg/dL), direct bilirubin (1.62 mg/dL, refer-
ence value <0.2 mg/dL). Serum CA 125 (86 U/mL, reference 
value 0–35 U/mL), CA 19-9 (50 U/mL, reference value 0–27 
U/mL), and CA 15-3 (38 U/mL, reference value 0–28 U/mL) 
levels were also increased, as mentioned before.
Results
Contrast-enhanced CT of the chest showed lymph nodes 
in the bilateral hilar region and mediastinum, with a maxi-
mum short axis diameter of 14 mm (Figure 1A, 1B). The lung 
parenchyma was normal. Abdominal CT revealed multiple 
hypodense, ill-defined, variable-sized (ranging from 5 mm 
to 15 mm in diameter) nodular lesions in the liver. The most 
striking characteristic of the lesions was the absence of a 
mass effect. Vascular architecture in the region of the lesions 
around the portal and hepatic veins was intact (Figure 2A, 2B).
Ultrasound-guided tru-cut liver biopsy using an 18-gauge 
needle showed typical sarcoidosis with granulomatous 
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inflammation without caseating granuloma or acid-fast 
bacilli.
Discussion
Sarcoidosis is a multisystem disease of unknown etiology 
characterized by proliferation of noncaseating granulomas. 
The mediastinal and hilar lymph nodes and lung parenchy-
ma are the most commonly affected sites, being involved in 
up to 90% of patients [1]. Liver biopsy demonstrates granu-
lomas histologically in 50–65% of the patients. Therefore, 
sarcoidosis of the liver is often histologically present in 
patients but usually patients have no symptoms related to 
liver disease [2]. Symptomatic liver disease occurs in less 
than 5% of patients with sarcoidosis. Systemic symptoms 
are represented by fever, physical exhaustion and jaundice 
(consistent with cholestasis) which were also present in our 
patient because of the hepatic involvement. Chronic intra-
hepatic cholestasis due to sarcoidosis can mimic sclerosing 
cholangitis or primary biliary cirrhosis [3,4].
The most common abnormal presentation of liver function 
tests in hepatic sarcoidosis is an elevation in serum alka-
line phosphatase level. However, this finding is only pre-
sent in as few as 15% of patients with histological evidence 
of the disease. Hyperbilirubinemia may also rarely occur 
with chronic progressive disease [5]. Both of these manifes-
tations were present in our patient.
Hepatomegaly is the most common liver abnormality seen 
on CT but was not present in our case [6,7]. Multiple focal 
hepatic lesions, most of which are small (mean diameter of 
1.0 cm) are found in less than 5% of patients with sarcoido-
sis. Hepatic nodules are seen less frequently than splenic 
nodules. Although nodular lesions are reported to be seen 
mostly in patients presenting with hepatomegaly, our 
patient had normal liver size with multiple nodular lesions 
[7]. Differences in immunological response to the disease 
may be a possible reason for the difference.
The differential diagnosis of hypodense multiple hepatic 
nodules includes tuberculosis, metastatic disease, fas-
cioliasis, candidiasis, Langerhans’ cell histiocytosis (LCH), 
and lymphoma. Hepatic tuberculosis is divided into two 
groups: miliary form and local form. Miliary pattern is 
seen as multiple hypodense nodules mostly less than 3 
mm in diameter on CT. The local form manifests as mul-
tiple hypodense hepatic lesions with hepatomegaly or a 
single tumorlike mass. The definitive diagnosis of hepat-
ic tuberculosis can only be made by histopathological 
Figure 1.  Contrast enhanced axial CT scan of the thorax. The images demonstrate (A) precarinal (black arrow), subaortic (white arrow) (B) bilateral 
hilar and subcarinal lymphadenopathies (white arrows).
A B
Figure 2.  (A, B) Enhanced axial CT scan of the abdomen. The images demonstrate multiple hypodense ill-defined, variable-sized, nodular lesions. 
Note the intact vascular architecture around the lesions.
A B
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examination [8]. After intravenous contrast medium injec-
tion, liver metastases usually enhance less than the sur-
rounding liver. The enhancement pattern is typically 
peripheral and a washout of contrast medium from the 
lesions is seen in the delayed phase [9]. Hepatic fascioliasis 
includes multiple, small, hypodense lesions, with periph-
eral contrast enhancement on CT. Focal thickening of the 
liver capsule and subcapsular, low-attenuation branching 
tracts can be demonstrated on CT [10]. Hepatic candidiasis 
is usually observed in immunocompromised hosts. On con-
trast-enhanced CT, fungal microabscesses usually appear as 
multiple, discrete, low-density, nodular lesions of similar 
size with peripheral contrast enhancement [11]. Hepatic 
Langerhans’ cell histiocytosis (LCH) presents as a focal nod-
ular disease. Accompanying lytic bone lesions are impor-
tant for the differential diagnosis [12]. Solid, hypodense, 
nodular lesions are also seen in hepatic lymphoma but 
existence of lymphadenopaties with periportal location 
of the lesions and disruption of the vascular architecture 
are helpful in making the differential diagnosis. Hepatic 
involvement in lymphoma is often seen as a secondary 
form in patients with known disease [13].
Conclusions
Hepatic involvement in sarcoidosis might be a perplexing 
diagnostic problem. The decisive CT finding with respect to 
the differential diagnosis was the absence of a mass effect 
and intact vascular architecture around the lesions. In 
addition, bilateral hilar and mediastinal lymphadenopathy 
is most commonly identified by a chest x-ray or CT.
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